PER 4.94% 8.5¢ percheron therapeutics limited

things are not looking good for Sarepta..Sp keeps fallingTells...

  1. 13,075 Posts.
    lightbulb Created with Sketch. 1363
    things are not looking good for Sarepta..
    Sp keeps falling
    Tells me
    investors are selling in the belief that the FDA will not approve SRP901 for the whole DMD population..
    due on the 21st of June or before..

    What does it mean for Sarepta

    Srp901 a gene therapy drug will not be financial without a larger population
    so
    all 4 of Sareptas drugs don’t show efficacy .. FDA could put pressure on Sarepta to correct that

    Per with proven ( combination therapy) could help keep Sareptas drugs on the mahttps://hotcopper.com.au/data/attachments/6241/6241547-9627bd5e36dfc032bcde29994c752615.jpg
    rket.
    Per as spoken by Management could treat 100% of the DMD market…



 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.5¢
Change
0.004(4.94%)
Mkt cap ! $76.63M
Open High Low Value Volume
8.1¢ 8.5¢ 8.1¢ $46.54K 563.7K

Buyers (Bids)

No. Vol. Price($)
2 164616 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.5¢ 100110 1
View Market Depth
Last trade - 15.55pm 28/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.